FABP4 possessed a well-established role in the pathogenesis of diabetes and atherosclerosis (Furuhashi et al., 2007; Erbay et al., 2009), however, the effect of FABP4 in rhabdomyolysis-induced AKI has not been determined. The gene discussed is FABP4; the disease is atherosclerosis.